Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Consensus
Hold3.17 / 5
6 ratings · Buy 2 · Hold 3 · Sell 1
Price vs analyst targets
Revenue and EPS estimates
Reported
Consensus estimates
Fiscal period
FY2023Dec '23
FY2024Dec '24
FY2025Dec '25
FY2026Dec '26
FY2027Dec '27
FY2028Dec '28
FY2029Dec '29
Revenue (B)
3.78
4.64
5.16
5.07
5.36
5.37
5.83
Growth YoY
+179.7%
+22.9%
+11.3%
−1.8%
+5.8%
0.0%
+8.7%
High estimate
–
–
–
5.16
5.45
5.87
6.58
Low estimate
–
–
–
4.96
5.26
4.75
5.51
Analysts
–
–
–
8
9
8
6
EPS, adjusted
−0.06
0.17
0.51
0.34
0.51
0.79
0.64
Growth YoY
n/m
n/m
+201.8%
−34.2%
+50.7%
+55.9%
−19.2%
High estimate
–
–
–
0.36
0.66
1.05
0.75
Low estimate
–
–
–
0.32
0.41
0.46
0.59
Analysts
–
–
–
4
4
4
1
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
9 firms active in the last 12 months
Firm
Analyst
Rating
Prev rating
Target
Prev target
Chg
Upside
Date
UBS
–
Sell
Buy
$9.50
–
–
+125%
Nov 12
Susquehanna
Joseph Stauff
Neutral
Positive
$7.00
$8.00
−13%
+66%
Nov 5
Capital One Financial
–
–
–
$5.50
–
–
+30%
Oct 16
Piper Sandler
–
–
–
$5.50
–
–
+30%
Oct 16
CBRE
John DeCree
–
–
$8.50
–
–
+101%
Aug 17
JP Morgan
–
Neutral
Neutral
–
–
–
–
Jul 16
Citigroup
–
Buy
Buy
–
–
–
–
Jul 10
CLSA
Jeffrey Kiang
Outperform
Hold
$6.00
$6.10
−2%
+42%
Jul 10
Morgan Stanley
Praveen Choudhary
Equal Weight
Overweight
$6.00
$9.60
−38%
+42%
Jun 22
Latest analyst action · Page refreshed hourly; analyst feeds refreshed daily · About this data